Literature DB >> 29126699

Subcutaneous treprostinil in pediatric patients with failing single-ventricle physiology.

Stephanie S Handler1, Michelle T Ogawa1, Rachel K Hopper1, Charlotte Sakarovitch2, Jeffrey A Feinstein3.   

Abstract

Entities:  

Year:  2017        PMID： 29126699     DOI： 10.1016/j.healun.2017.09.008

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  3 in total

Review 1.  Drug Treatment of Pulmonary Hypertension in Children.

Authors:  Catherine M Avitabile; Erika E Vorhies; David Dunbar Ivy
Journal:  Paediatr Drugs       Date:  2020-04       Impact factor: 3.022

2.  Pharmacokinetics of treprostinil in children with functional single-ventricle pulmonary arterial hypertension: a randomized controlled trial.

Authors:  Xi Chen; Xiao-Man Cai; Ming-Jie Zhang; Jing-Han Xu; Hao Li; Zhuo-Ming Xu
Journal:  Ann Transl Med       Date:  2021-07

3.  Pulmonary Vasodilator Therapy in Children with Single Ventricle Physiology: Effects on Saturation and Pulmonary Arterial Pressure.

Authors:  Ida Jeremiasen; Karin Tran-Lundmark; Nikmah Idris; Phan-Kiet Tran; Shahin Moledina
Journal:  Pediatr Cardiol       Date:  2020-07-30       Impact factor: 1.655
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.